| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.06 |